HOME >> MEDICINE >> NEWS
UI-led study shows experimental anti-cancer drug also has anti-HIV properties

The results of a study led by a University of Iowa researcher suggest that a drug already undergoing stage I and II clinical trials as a cancer treatment may also have potential as an anti-HIV therapy.

The study, led by David Price, Ph.D., a UI professor of biochemistry working with Matija Peterlin at the University of California San Francisco and Adrian Senderowicz at the National Cancer Institute, found that very low concentrations of flavopiridol, a drug manufactured by Aventis Inc., blocks HIV-1 replication in cell culture experiments. These findings appeared in the July 21 online issue of the Journal of Biological Chemistry.

Flavopiridol strongly hinders the cellular process known as transcription, a multi-step process which results in the production of ribonucleic acid (RNA). Cells use the genetic information encoded by these long RNA molecules to make proteins.

Flavopiridol effectively blocks the action of an enzyme called P-TEFb, which controls one of the steps in the transcription process. In fact, flavopiridol is the most powerful P-TEFb inhibitor to date. In Price's test tube experiments, even extremely low concentrations of flavopiridol were effective at blocking the action of P-TEFb.

P-TEFb is required for transcription of the HIV-1 genome to occur. Flavopiridol inhibits P-TEFb, causing inhibition of transcription. In tests to investigate its effect on HIV-1 infection and viral spread in cultured human cells, Price's team found that the same low concentrations of flavopiridol that inhibited P-TEFb dramatically blocked HIV-1 infection and replication.

"Since P-TEFb is a key factor in HIV-1 infection and flavopiridol blocks HIV-1 propagation in culture, we believe that this substance should be tested as a potential anti-AIDS drug," Price said.

During infection, HIV-1 undergoes mutations in its DNA that allow its proteins to change and become resistant to drugs. This is one of the biggest problems with treatment of HIV. Many
'"/>

Contact: Jennifer Brown
brownj@mail.medicine.uiowa.edu
319-335-9917
University of Iowa
2-Aug-2000


Page: 1 2

Related medicine news :

1. UI-led study indicates surgery is the best treatment for severe Bells palsy paralysis
2. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
3. UMaine study looks at infants and chronic nighttime crying
4. Chronic pain treatments more effective when taken together, new study shows
5. UNC study: Most N.C. family practitioners engage in unrecognized community service
6. New study in Nature demonstrates protection against cell death during heart attack
7. UCSF study offers insight into human circadian rhythms
8. International breast cancer prevention study launches in the United States and Canada
9. UW study shows blacks and Latinos are more satisfied with physicians of the same race
10. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
11. Advertising by academic medical centers may risk eroding public trust, says study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2019)... , ... February 13, 2019 , ... ... 2019, at the company’s annual member conference, Elevate 2019 at the Gaylord Rockies ... staff and members to explore potential partnerships driving improved quality of patient care, ...
(Date:2/13/2019)... ... February 13, 2019 , ... American Vision Partners, ... the nation, announced a new addition to their growing list of ophthalmology brands: ... within a multi-specialty ophthalmology practice. , Dr. Zachary Berbos, MD, FACS, ...
(Date:2/13/2019)... ... February 13, 2019 , ... Asana Recovery is accepting ... students who choose to pursue a medical-related course of study in California, the $1,000 ... substance abuse disorder and mental health treatment, and how it has led them to ...
(Date:2/12/2019)... ... February 12, 2019 , ... Medical Device Risk ... Ombu Enterprises**, Feb. 19-20, 2019, Atlanta, GA , https://www.fdanews.com/mdriskmanagement , One ... of Change on Jan. 22 , Risk management is just plain hard, complicated, ...
(Date:2/11/2019)... ... February 11, 2019 , ... Caring Health Systems ... integrated suite could more effectively manage its complex environment of 1,100+ employees across ... client, Caring Health chose SmartLinx to automate its changing staffing needs, such as ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... ... February 13, 2019 , ... The Medicus Firm (TMF) ... Physician Recruiters (ASPR). “The Medicus Firm has been a vocal and enthusiastic supporter ... stewardship and support of educational programs are part of our DNA and becoming a ...
(Date:2/13/2019)... , ... February 13, 2019 , ... Co-founded in a ... aims to give women an empowering place to not only exercise, but to nurture ... CEO Devan is a former professional baseball player with the San Francisco Giants and ...
(Date:2/13/2019)... & ORLANDO, Fla. (PRWEB) , ... February 13, ... ... platform for voice and chatbot applications in healthcare, today announced through its collaboration ... two additional platforms: Google Assistant and voice-powered web chat. This takes Mayo ...
Breaking Medicine Technology:
Cached News: